LIFEVEST WCD 4000 SYSTEM
Report
- Report Number
- 3008642652-2013-00872
- Event Type
- Malfunction
- Date Received
- April 5, 2013
- Date of Event
- March 11, 2013
- Report Date
- March 28, 2013
- Manufacturer
- ZOLL LIFECOR CORPORATION
- Product Code
- MVK
- PMA / PMN Number
- P010030
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- BIOMEDICAL ENGINEER
Narratives
DEVICE EVAL SUMMARY - DEVICE EVALUATION OF BATTERY CHARGER SN (B)(4) IS CURRENTLY UNDERWAY. AS RECEIVED, THE BATTERY CHARGER WOULD NOT POWER ON. UPON SERVICE INVESTIGATION, THERE WAS AN MD5 FAILURE DURING REPROGRAMMING OF THE CHARGER, WHICH IS A FLASH MEMORY FAILURE. THE CAUSE OF THE CHARGER NOT POWERING ON WAS ISOLATED TO FLASH MEMORY COMPONENTS U102 AND U105 ON THE COMPUTER / ANALOG BOARD. THE FLASH MEMORY HAD AN INTERMITTENT BGA CONNECTION. THE INTERMITTENT CONNECTION IS LIKELY DUE TO A FRACTURED SOLDER CONNECTION INDUCED BY MECHANICAL STRESS. THE EXACT SOURCE OF THE MECHANICAL STRESS HAS NOT BEEN POSITIVELY IDENTIFIED BUT THE FRACTURED CONNECTION MAY HAVE BEEN ACCELERATED THROUGH ROUGH HANDLING. ROOT CAUSE ANALYSIS OF SIMILAR EVENTS FOUND THAT EXCESSIVE STRAIN ON THE PRINTED CIRCUIT ASSEMBLY (PCA) FROM SEVERE IMPACT CAN CAUSE FRACTURED SOLDER CONNECTIONS. A MECHANICAL DESIGN CHANGE TO REDUCE THE PCA STRAIN WAS SUBMITTED FOR FDA REVIEW ON (B)(4) 2013 AND IS CURRENTLY UNDER REVIEW. NO ADVERSE EVENT RESULTED FROM THE DEFECTIVE COMPONENTS. THE LAST PT TO USE THIS BATTERY CHARGER/MODEM DID NOT REPORT ANY DEFICIENCIES.
A REVIEW OF SERVICE DATA DETECTED A REPORTABLE PROBLEM. DURING SERVICING, BATTERY CHARGER/MODEM SN (B)(4) WOULD NOT POWER UP. THE LAST PT TO USE THIS BATTERY CHARGER/MODEM DID NOT REPORT ANY ISSUES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 142030 | LIFEVEST WCD 4000 SYSTEM | WEARABLE CARDIOVERTER DEFIBRILLATOR | MVK | ZOLL LIFECOR CORPORATION | WCD 4000 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA |